Gene expression changes triggered by exposure of Haemophilus influenzae to Novobiocin or ciprofloxacin: Combined transcription and translation analysis [1]

Genome Research

Volumn 11, Issue 1, 2001, Pages 28-42

  Gmuender, H ^a   Kuratli, K ^a   Di Padova, K ^a   Gray, C P ^a   Keck, W ^a   Evers, S ^a  

^a F HOFFMANN LA ROCHE LTD   (Switzerland)

Author keywords

[No Author keywords available]

Indexed keywords

ADENOSINE TRIPHOSPHATASE; BACTERIAL DNA; BACTERIAL PROTEIN; BACTERIAL RNA; CIPROFLOXACIN; DNA TOPOISOMERASE (ATP HYDROLYSING); GYRASE INHIBITOR; NOVOBIOCIN;

BACTERIAL GENE; CONTROLLED STUDY; DNA CLEAVAGE; DNA DAMAGE; DNA MICROARRAY; DNA REPAIR; DNA SUPERCOILING; DRUG EXPOSURE; ENZYME INHIBITION; GENE EXPRESSION; GENETIC ANALYSIS; GENETIC TRANSCRIPTION; HAEMOPHILUS INFLUENZAE; LETTER; NONHUMAN; NUCLEOTIDE SEQUENCE; PRIORITY JOURNAL; PROTEIN ANALYSIS; RNA TRANSLATION; TWO DIMENSIONAL ELECTROPHORESIS;

BACTERIAL PROTEINS; CIPROFLOXACIN; DNA TOPOISOMERASES, TYPE II; ELECTROPHORESIS, GEL, TWO-DIMENSIONAL; ENZYME INHIBITORS; GENE EXPRESSION REGULATION, BACTERIAL; HAEMOPHILUS INFLUENZAE; NOVOBIOCIN; PROTEIN BIOSYNTHESIS; REPRODUCIBILITY OF RESULTS; RNA, BACTERIAL; RNA, MESSENGER; SENSITIVITY AND SPECIFICITY; TRANSCRIPTION, GENETIC;

BACTERIA (MICROORGANISMS); HAEMOPHILUS INFLUENZAE; NEGIBACTERIA;

EID: 0035154372     PISSN: 10889051     EISSN: None     Source Type: Journal    
DOI: 10.1101/gr.157701     Document Type: Letter

References (48)

1. The 43-kilodalton N-terminal fragment of the DNA gyrase B protein hydrolyzes ATP and binds coumarin drugs
2. Nucleotide binding to the 43-kilodalton N-terminal fragment of the DNA gyrase B protein
3. A comparison of selected mRNA and protein abundances in human liver
4. Genetic systems in Haemophilus influenzae
5. Isolation and characterization of a ciprofloxacin-resistant isolate of Haemophilus influenzae from the Netherlands
6. The EIIGlc protein is involved in glucose-mediated activation of Escherichia coli gapA and gapB-pgk transcription
7. Accessing genetic information with high-density DNA arrays
8. gyrB mutations which confer coumarin resistance also affect DNA supercoiling and ATP hydrolysis by Escherichia coli DNA gyrase
9. Microarray based identification of a novel Streptococcus pneumoniae regulon controlled by an-autoinduced-peptide
10. DNA gyrase, topoisomerase IV, and the 4-quinolones
11. Whole-genome random sequencing and assembly of Haemophilus influenzae Rd
12. Light-directed spatially addressable parallel chemical synthesis
13. Multiplexed biochemical assays with biological chips
14. Primary targets of fluoroquinolones in Streptococcus pneumoniae
15. Effect of pyrimido[1,6-a]benzimidazoles, quinolones, and Ca2+ on the DNA gyrase-mediated cleavage reaction
16. In the presence of subunit A inhibitors DNA gyrase cleaves DNA fragments as short as 20 bp at specific sites
17. Cyclothialidine and its congeners: A new class of DNA gyrase inhibitors
18. The interaction of coumarin antibiotics with fragments of the DNA gyrase B protein
19. Correlation between protein and mRNA abundance in yeast
20. Quinolone mode of action-New aspects
21. Mode of action of the new quinolones: New data
22. Pyrimido[1,6-a]benzimidazoles: A new class of DNA gyrase inhibitors
23. Estimation of the effect of coumermycin A1 on Salmonella typhimurium promoters by using random operon fusions
24. Disassembly of the post-termination complex and reduction of translational error by ribosome recycling factor (RRF)-A possible new target for antibacterial agents
25. Probing the binding of coumarins and cyclothialidines to DNA gyrase
26. Two-dimensional map of the proteome of Haemophilus influenzae
27. The nature of inhibition of DNA gyrase by the coumarins and the cyclothialidines revealed by X-ray crystallography
28. Expression monitoring by hybridization to high-density oligonucleotide arrays
29. The twisted 'life' of DNA in the cell: Bacterial topoisomerases
30. The interaction between coumarin drugs and DNA gyrase
31. DNA gyrase as a drug target
32. The biochemistry and biology of DNA gyrase
33. ParC subunit of DNA topoisomerase IV of Streptococcus pneumoniae is a primary target of fluoroquinolones and cooperates with DNA gyrase A subunit in forming resistance phenotype
34. Mechanism of inhibition of DNA gyrase by cyclothialidine, a novel DNA gyrase inhibitor
35. Characterization of the binding site for cyclothialidine on the B subunit of DNA gyrase
36. Mode of action of GR122222X, a novel inhibitor of bacterial DNA gyrase
37. Induction of the SOS response in Escherichia coli by 4-quinolone antimicrobial agents
38. Correlation of quinolone MIC and inhibition of DNA, RNA and protein synthesis and induction of the SOS response in Escherichia coli
39. DNA gyrase: Structure and function
40. The mechanisms of DNA topoisomerases
41. Inside SWISS 2DPAGE database
42. DNA topoisomerases
43. Topoisomerase mutations affect the relative abundance of many Escherichia coli proteins
44. Probing the role of the ATP-operated clamp in the strand-passage reaction of DNA gyrase
45. The effect of mutations in the SOS response on the kinetics of quinolone killing
46. Transcription and DNA supercoiling
47. Genome-wide expression monitoring in Saccharomyces cerevisiae
48. Diverse mechanisms for regulating ribosomal protein synthesis in Escherichia coli